---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-085650"
form_type: "8-K"
ticker: "IOVA"
cik: "0001425205"
company_name: "IOVANCE BIOTHERAPEUTICS, INC."
filed_at: "2025-08-29T23:59:59+00:00"
generated_at: "2026-05-17T09:11:08.929689+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Iovance posts updated corporate presentation for August 2025; no specific details disclosed

## Summary
- Company filed an 8-K announcing a revised corporate presentation dated August 2025.
- Presentation is used at healthcare conferences and for discussions with analysts and stockholders.
- Exhibit 99.1 incorporated by reference but full content not provided in this filing excerpt.
- No financial or clinical milestones were explicitly stated in the filing body.

## SEC filing metadata
- accession: 0001104659-25-085650
- form_type: 8-K
- ticker: IOVA
- cik: 0001425205
- company_name: IOVANCE BIOTHERAPEUTICS, INC.
- filed_at: 2025-08-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425205/000110465925085650/0001104659-25-085650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425205/000110465925085650/tm2524604d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-085650
- JSON: https://secwatch.observer/filing/0001104659-25-085650.json
- Plain text: https://secwatch.observer/filing/0001104659-25-085650.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.